Sodium-glucose co-transporter 2 inhibitor empagliflozin inhibits the cardiac Na(+)/H(+) exchanger 1: persistent inhibition under various experimental conditions

Detalles Bibliográficos
Autores principales: Zuurbier, Coert J, Baartscheer, Antonius, Schumacher, Cees A, Fiolet, Jan W T, Coronel, Ruben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683702/
https://www.ncbi.nlm.nih.gov/pubmed/33792689
http://dx.doi.org/10.1093/cvr/cvab129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683702/
https://www.ncbi.nlm.nih.gov/pubmed/33792689
http://dx.doi.org/10.1093/cvr/cvab129

Ejemplares similares